Literature DB >> 9560207

Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.

F M Dautzenberg1, S Wille, R Lohmann, J Spiess.   

Abstract

The nonselective human corticotropin-releasing factor receptor 1 (hCRF-R1) and the ligand-selective Xenopus CRF-R1 (xCRF-R1) were compared. To understand the interactions of sauvagine and ovine CRF, both high-affinity ligands for hCRF-R1 but surprisingly weak ligands for xCRF-R1, chimeric receptors of hCRF-R1 and xCRF-R1 followed by double or multiple point mutations were constructed. Binding studies and cAMP assays demonstrated that the N-terminal domain exhibited the complete ligand selectivity of xCRF-R1. The important region was mapped between amino acids 70 and 89; replacement of amino acids Arg76, Asn81, Gly83, Leu88, and Ala89 in hCRF-R1 with the corresponding amino acids of xCRF-R1 (Gln76, Gly81, Val83, His88, and Leu89) resulted in a receptor that had approximately 30-fold higher affinity for human/rat CRF than for sauvagine. Mutagenesis of these amino acids in xCRF-R1 to the human sequence completely abolished the ligand selectivity of xCRF-R1. Mutagenesis of amino acids 88 and 89 in hCRF-R1 or xCRF-R1 had only a minor (approximately 2.5-fold) effect on the ligand selectivity of the mutant receptor. Substitution of Arg76, Asn81, and Gly83 in hCRF-R1 with the corresponding sequence of xCRF-R1 (Gln76, Gly81, and Val83) resulted in a receptor with approximately 11-fold higher affinity for human/rat CRF compared with ovine CRF or sauvagine. When only two of these three amino acids were mutated, no effect on the ligand selectivity was observed. On the basis of these data, it is suggested that amino acids 70-89 of CRF-R1 are important for the ligand binding site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560207      PMCID: PMC20192          DOI: 10.1073/pnas.95.9.4941

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

Authors:  A J Dunn; C W Berridge
Journal:  Brain Res Brain Res Rev       Date:  1990 May-Aug

Review 2.  Physiology and pharmacology of corticotropin-releasing factor.

Authors:  M J Owens; C B Nemeroff
Journal:  Pharmacol Rev       Date:  1991-12       Impact factor: 25.468

3.  The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.

Authors:  M H Perrin; S Sutton; D L Bain; W T Berggren; W W Vale
Journal:  Endocrinology       Date:  1998-02       Impact factor: 4.736

4.  Clinical studies with synthetic ovine corticotropin-releasing factor.

Authors:  D N Orth; C R DeBold; G S DeCherney; R V Jackson; W R Sheldon; W E Nicholson; H Uderman; A N Alexander; D P Island; J Rivier
Journal:  Fed Proc       Date:  1985-01

5.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

6.  Structural basis of beta-adrenergic receptor function.

Authors:  C D Strader; I S Sigal; R A Dixon
Journal:  FASEB J       Date:  1989-05       Impact factor: 5.191

7.  Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus.

Authors:  K Lederis; A Letter; D McMaster; G Moore; D Schlesinger
Journal:  Science       Date:  1982-10-08       Impact factor: 47.728

8.  Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core.

Authors:  R A Dixon; I S Sigal; E Rands; R B Register; M R Candelore; A D Blake; C D Strader
Journal:  Nature       Date:  1987 Mar 5-11       Impact factor: 49.962

9.  Primary structure of corticotropin-releasing factor from ovine hypothalamus.

Authors:  J Spiess; J Rivier; C Rivier; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Molecular cloning and expression of a cDNA encoding the secretin receptor.

Authors:  T Ishihara; S Nakamura; Y Kaziro; T Takahashi; K Takahashi; S Nagata
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  8 in total

1.  Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand.

Authors:  Christy Rani R Grace; Marilyn H Perrin; Jozsef Gulyas; Michael R Digruccio; Jeffrey P Cantle; Jean E Rivier; Wylie W Vale; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-12       Impact factor: 11.205

2.  Corticotropin releasing factor 2 receptor agonists reduce the denervation-induced loss of rat skeletal muscle mass and force and increase non-atrophying skeletal muscle mass and force.

Authors:  R T Hinkle; E Donnelly; D B Cody; M B Bauer; R J Sheldon; R J Isfort
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

3.  Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1.

Authors:  Augen A Pioszak; Naomi R Parker; Kelly Suino-Powell; H Eric Xu
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

Review 4.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

5.  Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2.

Authors:  J Radulovic; A Rühmann; T Liepold; J Spiess
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

6.  Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1.

Authors:  B A Hofmann; S Sydow; O Jahn; L van Werven; T Liepold; K Eckart; J Spiess
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

7.  NMR structure of the first extracellular domain of corticotropin-releasing factor receptor 1 (ECD1-CRF-R1) complexed with a high affinity agonist.

Authors:  Christy Rani R Grace; Marilyn H Perrin; Jozsef Gulyas; Jean E Rivier; Wylie W Vale; Roland Riek
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

Review 8.  Regulatory Pathways of Monoamine Oxidase A during Social Stress.

Authors:  Yuki Higuchi; Tomoko Soga; Ishwar S Parhar
Journal:  Front Neurosci       Date:  2017-10-31       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.